Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Amortization of Deferred Charges: 2024-2025

Historic Amortization of Deferred Charges for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $141,000.

  • Kura Oncology's Amortization of Deferred Charges rose 5.22% to $141,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $552,000, marking a year-over-year change of. This contributed to the annual value of $523,000 for FY2024, which is 9.64% up from last year.
  • Latest data reveals that Kura Oncology reported Amortization of Deferred Charges of $141,000 as of Q3 2025, which was up 2.17% from $138,000 recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Amortization of Deferred Charges peaked at $141,000 during Q3 2025, and registered a low of $122,000 during Q1 2024.